An examination of calcium current function on heterotopic neurons in hippocampal slices from rats exposed to methylazoxymethanol

Epilepsia. 2003 Mar;44(3):315-21. doi: 10.1046/j.1528-1157.2003.41102.x.

Abstract

Purpose: To study voltage-dependent calcium currents (VDCCs) on hippocampal heterotopic neurons by using whole-cell patch-clamp techniques in brain slices prepared from methylaxozymethanol (MAM)-exposed rats.

Methods: Whole-cell voltage-clamp recordings were obtained from visually identified neurons in acute brain slices by using an infrared differential interference contrast (IR-DIC) video microscopy system. Heterotopic neurons were compared with normotopic pyramidal cells in hippocampal slices from MAM-exposed rats or CA1 pyramidal neurons in slices from controls.

Results: Heterotopic neurons expressed a prominent VDCC, which exhibited a peak current maximum around -30 mV (holding potential, -60 mV) and an inactivation time constant of 48.2 +/- 2.4 ms (n = 91). VDCC peak current and inactivation time constants were similar for normotopic (n = 92) and CA1 pyramidal cells (n = 40). Pharmacologic analysis of VDCC, on heterotopic, normotopic, and CA1 pyramidal cells, revealed an approximately 70% blockade of peak Ca2+ current with nifedipine and amiloride (L- and T-type channel blockers, respectively). Inhibition of VDCC, for all three cell types, also was similar when more specific Ca2+ channel antagonists were used [e.g., omega-conotoxin GVIA (N-type), omega-agatoxin KT (P/Q-type), and sFTX-3.3 (P-type)]. VDCC modulation by norepinephrine (NE) or adrenergic receptor-specific agonists [clonidine (alpha2), isoproterenol (beta), and phenylephrine (alpha1)] was similar for heterotopic and CA1 pyramidal cells.

Conclusions: Heterotopic neurons do not appear to exhibit Ca2+ channel abnormalities that could contribute to the reported hyperexcitability associated with MAM-exposed rats.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium / physiology
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Choristoma / chemically induced*
  • Choristoma / physiopathology*
  • Disease Models, Animal
  • Electrophysiology
  • Epilepsy / chemically induced
  • Epilepsy / physiopathology*
  • Female
  • Hippocampus / abnormalities*
  • Hippocampus / drug effects
  • Hippocampus / physiopathology*
  • Humans
  • In Vitro Techniques
  • Methylazoxymethanol Acetate* / analogs & derivatives*
  • Methylazoxymethanol Acetate* / pharmacology
  • Nervous System Malformations / chemically induced*
  • Nervous System Malformations / physiopathology*
  • Neurons / drug effects
  • Neurons / physiology*
  • Patch-Clamp Techniques
  • Potassium Channels / physiology
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Teratogens* / pharmacology

Substances

  • Calcium Channels
  • Potassium Channels
  • Teratogens
  • Methylazoxymethanol Acetate
  • methylazoxymethanol
  • Calcium